Everence Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Everence Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-52,730	Closed	-$211K	–	702
2019 Q4	$211K	Hold	52,730	–	–	0.03%	600
2019 Q3	$258K	Hold	52,730	–	–	0.04%	482
2019 Q2	$321K	Hold	52,730	–	–	0.05%	410
2019 Q1	$306K	Buy	+52,730	New	+$544K	0.05%	401

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Everence Capital Management's DPLO Position: Q1 2020 in Review

Everence Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 52,730 shares — an estimated $211K sold.

Everence Capital Management first reported a position in DPLO in Q1 2019 and held it in 4 quarters. The position peaked at $321K in Q2 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Everence Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Everence Capital Management sold 52,730 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $211K.
Everence Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2019 and held it in 4 quarters.
Everence Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $321K in Q2 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Everence Capital Management's 13F filing for Q1 2020, filed 23 Apr 2020.